K. Zelenakas - Concepedia

Author

K. Zelenakas

Also Known As

K Zelenakas, K. Zelenakas, Ken Zelenakas

Publications

787

Citations

H-Index

Concepts

All Affiliations

K. Zelenakas is an author at Novartis (United States) specializing in bone health, medicine, and osteoporosis.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	93
2	Health Sciences	1	1	43
3	Diagnostic Sciences	1	1	43
4	Orthopaedics	1	1	43
5	Pharmacology	1	1	43

K. Zelenakas

Publications

785

Citations

H-Index

Page 1

	Year	Citations
Comparison of a Single Infusion of Zoledronic Acid with Risedronate for Paget's Disease Ian R. Reid, Paul D. Miller, Kenneth W. Lyles, New England Journal of Medicine	2005	429
Long-Term Control of Bone Turnover in Paget's Disease With Zoledronic Acid and Risedronate David Hosking, Kenneth W. Lyles, Jacques P. Brown, Journal of Bone and Mineral Research	2006	159
Pamidronate in the treatment of bone metastases: results of 2 dose-ranging trials in patients with breast or prostate cancer. Allan Lipton, Donna Glover, Harold A. Harvey, PubMed	1994	57
Antiresorptive Effect of a Single Infusion of Microgram Quantities of Zoledronate in Paget's Disease of Bone M. Arden-Cordone, Ethel S. Siris, Kenneth W. Lyles, Calcified Tissue International Bone DiseaseAntiresorptive EffectBone HealthMicrogram QuantitiesSingle Infusion	1997	50
Analgesic efficacy of single oral doses of lumiracoxib and ibuprofen in patients with postoperative dental pain K. Zelenakas, James R. Fricke, S. Jayawardene, International Journal of Clinical Practice	2004	47
Single infusion of zoledronate in Paget’s disease of bone: a placebo-controlled, dose-ranging study Helen Buckler, William D. Fraser, D. J. Hosking, Bone Paget ’Single InfusionCancer ManagementDose-ranging StudyOsteoporosis	1999	43

Page 1